Advanced search
Publication Cover
OncoTargets and Therapy Volume 8, 2015 - Issue
Submit an article Journal homepage
64
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials

Xiaoping Liu1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Colin K He2 Orient Health Care, NYC, USA
,
Xiangyu Meng1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Li He1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Kaili Li1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Qing Liang1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China
,
Liang Shao1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Shangqin Liu1 Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 1459-1469 | Published online: 15 Jun 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xiaoping Liu, Jiarui Chen, Yuncen A He, Xiangyu Meng, Kaili Li, Colin K He & Shangqin Liu. (2017) Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials. OncoTargets and Therapy 10, pages 121-128.
Read now
Runzhe Chen, Xiaoping Zhang, Chong Gao, Chengxin Luan, Yujie Wang & Baoan Chen. (2017) Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study. Cancer Management and Research 9, pages 373-380.
Read now

Articles from other publishers (7)

Tung-Lung Yang, Chin Lin, Ching-Liang Ho, Tzu-Chuan Huang, Yi-Ying Wu, Hong-Jie Jhou, Po-Huang Chen & Cho-Hao Lee. (2023) Progression-Free Survival Efficacy in Refractory/Relapsed Multiple Myeloma among Elderly Patients: A Systematic Review. Life 13:12, pages 2259.
Crossref
Leona A. Holmberg, David G. Maloney & Laura Connelly-Smith. (2023) Bortezomib and Vorinostat Therapy as Maintenance Therapy Post-Autologous Transplant for Non-Hodgkin’s Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen. Acta Haematologica, pages 1-9.
Crossref
Leona A. Holmberg, Damian Green, Edward Libby & P.S. Becker. (2020) Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma. Acta Haematologica 143:2, pages 146-154.
Crossref
Rongxin Yao, Xudong Hu, Shuping ZhouQianying Zhang, He Huang, Ni Sun, Wenjian Guo, Kang Yu & Ying Lin. (2019) Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China. Medicine 98:39, pages e17147.
Crossref
Andrew J. Cowan, Philip A. Stevenson, Edward N. Libby, Pamela S. Becker, David G. Coffey, Damian J. Green, Teresa S. Hyun, Jonathan R. Fromm, Ajay K. Gopal & Leona A. Holmberg. (2018) Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy. Biology of Blood and Marrow Transplantation 24:7, pages 1386-1391.
Crossref
Jie-Li Li, Guang-Yu Fan, Yu-Jie Liu, Zi-Hang Zeng, Jing-Juan Huang, Zong-Ming Yang & Xiang-Yu Meng. (2018) Long-Term Efficacy of Maintenance Therapy for Multiple Myeloma: A Quantitative Synthesis of 22 Randomized Controlled Trials. Frontiers in Pharmacology 9.
Crossref
Patricia Melo Aguiar, Tácio de Mendonça Lima, Gisele Wally Braga Colleoni & Sílvia Storpirtis. (2017) Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: An overview of systematic reviews with meta-analyses. Critical Reviews in Oncology/Hematology 113, pages 195-212.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.